
European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate
MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …
Read More